Prabhakar Ramachandran, Rath Goura K, Julka Pramod K, Ganesh Tharmar, Haresh K P, Joshi Rakesh C, Senthamizhchelvan S, Thulkar Sanjay, Pant G S
Department of Radiotherapy & Oncology, Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India.
Med Dosim. 2008 Spring;33(1):81-5. doi: 10.1016/j.meddos.2007.03.003.
Setup error plays a significant role in the final treatment outcome in radiotherapy. The effect of setup error on the planning target volume (PTV) and surrounding critical structures has been studied and the maximum allowed tolerance in setup error with minimal complications to the surrounding critical structure and acceptable tumor control probability is determined. Twelve patients were selected for this study after breast conservation surgery, wherein 8 patients were right-sided and 4 were left-sided breast. Tangential fields were placed on the 3-dimensional-computed tomography (3D-CT) dataset by isocentric technique and the dose to the PTV, ipsilateral lung (IL), contralateral lung (CLL), contralateral breast (CLB), heart, and liver were then computed from dose-volume histograms (DVHs). The planning isocenter was shifted for 3 and 10 mm in all 3 directions (X, Y, Z) to simulate the setup error encountered during treatment. Dosimetric studies were performed for each patient for PTV according to ICRU 50 guidelines: mean doses to PTV, IL, CLL, heart, CLB, liver, and percentage of lung volume that received a dose of 20 Gy or more (V20); percentage of heart volume that received a dose of 30 Gy or more (V30); and volume of liver that received a dose of 50 Gy or more (V50) were calculated for all of the above-mentioned isocenter shifts and compared to the results with zero isocenter shift. Simulation of different isocenter shifts in all 3 directions showed that the isocentric shifts along the posterior direction had a very significant effect on the dose to the heart, IL, CLL, and CLB, which was followed by the lateral direction. The setup error in isocenter should be strictly kept below 3 mm. The study shows that isocenter verification in the case of tangential fields should be performed to reduce future complications to adjacent normal tissues.
摆位误差在放射治疗的最终治疗结果中起着重要作用。已经研究了摆位误差对计划靶区(PTV)和周围关键结构的影响,并确定了在对周围关键结构并发症最小且肿瘤控制概率可接受的情况下摆位误差的最大允许公差。本研究选取了12例保乳手术后的患者,其中8例为右侧乳腺,4例为左侧乳腺。通过等中心技术在三维计算机断层扫描(3D-CT)数据集上设置切线野,然后从剂量体积直方图(DVH)计算PTV、同侧肺(IL)、对侧肺(CLL)、对侧乳腺(CLB)、心脏和肝脏的剂量。将计划等中心在所有三个方向(X、Y、Z)上分别移动3毫米和10毫米,以模拟治疗过程中遇到的摆位误差。根据ICRU 50指南对每位患者的PTV进行剂量学研究:计算上述所有等中心移位情况下PTV、IL、CLL、心脏、CLB、肝脏的平均剂量以及接受20 Gy或更高剂量的肺体积百分比(V20);接受30 Gy或更高剂量的心脏体积百分比(V30);以及接受50 Gy或更高剂量的肝脏体积(V50),并与等中心零移位的结果进行比较。在所有三个方向上模拟不同的等中心移位表明,沿后方向的等中心移位对心脏、IL、CLL和CLB的剂量影响非常显著,其次是侧方向。等中心的摆位误差应严格控制在3毫米以下。该研究表明,在切线野情况下应进行等中心验证,以减少未来对相邻正常组织的并发症。